{"issuance_frequency":"","notes_translated":{"fr":"Les lignes directrices sur les modifications apportées au Règlement sur les aliments et drogues pour les médicaments contre la COVID-19 indiquent que les exigences d'étiquetage en langage clair pour les maquettes d'étiquettes et les dossiers d'évaluation de la marque ne s'appliquent pas [alinéas C.08.002(2)(j.1) et C.08.002(2)(o)]. Bien qu'ils ne soient pas tenus de le faire, les promoteurs sont invités à fournir une évaluation du nom de marque, si celle-ci est disponible.","en":"The guidance document concerning amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19 indicates that the plain language labelling requirements for mock-up labels and a brand name assessment package do not apply (C.08.002(2)(j.1) and C.08.002(2)(o)). Although not required, sponsors are invited to provide a brand name assessment should one be available."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"fcff290d-d253-4e4c-ae85-35d61d77968e","metadata_created":"2021-07-27T14:11:50.886987","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-07-27T14:11:50.886994","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-27","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["coronavirus","COVID-19","pandémie","médicaments","médicaments","vaccins","autorisation de mise en marché","licence","importation ou vente","vaccin COVID-19","exigences en matière d'étiquetage","exigences post-commercialisation"],"en":["coronavirus","COVID-19","pandemic","drugs","medications","vaccines","market authorization","licensing","importing or selling","COVID-19 vaccine","labelling requirements","post-market requirements"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Lignes directrices sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19 : Exigences d’étiquetage et de post-commercialisation","en":"Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirements"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"fcff290d-d253-4e4c-ae85-35d61d77968e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"7e910b60-5e4e-4b66-8301-cbb75f473399","related_relationship":"","name_translated":{"fr":"Lignes directrices sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19 : Exigences d’étiquetage et de post-commercialisation","en":"Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirements"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirements","language":["en"],"created":"2021-07-27T14:11:50.960751","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/guidance-market-authorization-vaccines/labelling-post-market-requirements.html","last_modified":null,"position":0,"revision_id":"41229173-ae77-4f61-a127-3ebc982a0663","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"fcff290d-d253-4e4c-ae85-35d61d77968e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"0a26a367-9d94-433e-af3c-f3cd180b1ab1","related_relationship":"","name_translated":{"fr":"Lignes directrices sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19 : Exigences d’étiquetage et de post-commercialisation","en":"Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirements"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirements","language":["fr"],"created":"2021-07-27T14:11:50.960758","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/ligne-directrices-autorisations-mise-marche-vaccins/exigences-etiquetage-post-commercialisation.html","last_modified":null,"position":1,"revision_id":"41229173-ae77-4f61-a127-3ebc982a0663","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2021-03-30 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"fcff290d-d253-4e4c-ae85-35d61d77968e","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The guidance document concerning amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19 indicates that the plain language labelling requirements for mock-up labels and a brand name assessment package do not apply (C.08.002(2)(j.1) and C.08.002(2)(o)). Although not required, sponsors are invited to provide a brand name assessment should one be available.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirements","revision_id":"41229173-ae77-4f61-a127-3ebc982a0663"}